Interaction Between Calcium Carbonate (Tums) and Dextroamphetamine
Pharmacokinetic Mechanism
- Calcium carbonate acts as an antacid that raises urinary pH (urinary alkalinization), which can diminish the ionization‑dependent renal clearance of weak‑base stimulants such as dextroamphetamine. American College of Endocrinology guidance. 1
- Alkaline urine reduces the renal elimination of amphetamines, leading to higher systemic exposure and a longer duration of action. American Academy of Child and Adolescent Psychiatry guidance. 2
Clinical Management
Timing of Administration
- Calcium carbonate requires gastric acid for optimal absorption and is therefore best taken with food; this timing increases the likelihood that the antacid will be present in the gastrointestinal tract when the stimulant is taken. American College of Endocrinology guidance. [1][3]
- The risk of interaction is greatest when dextroamphetamine and calcium carbonate are present in the body simultaneously; spacing the two agents by at least 2–4 hours reduces the chance of concurrent exposure. American Academy of Child and Adolescent Psychiatry guidance. 2
Monitoring for Interaction Effects
- Clinicians should watch for signs of increased amphetamine exposure, including heightened stimulant effects (elevated heart rate, blood pressure, anxiety), prolonged duration of action beyond the expected timeframe, and amplified side‑effects such as insomnia, reduced appetite, or irritability. American Academy of Child and Adolescent Psychiatry guidance. 2
Alternative Calcium Supplementation
- Calcium citrate is preferred over calcium carbonate for patients on dextroamphetamine because it does not depend on gastric acid for absorption and can be taken between meals, minimizing overlap with the stimulant. American College of Endocrinology guidance; National Comprehensive Cancer Network guidance. [3][4]
- Calcium citrate is associated with fewer gastrointestinal adverse events compared with calcium carbonate. American College of Endocrinology guidance. [5][3]
- For optimal calcium uptake, doses should be divided and limited to ≤ 500–600 mg per administration. American College of Endocrinology guidance. [5][3]
Safety Guidance from Practice Parameters
- Current stimulant practice parameters do not list a formal drug‑drug interaction warning between dextroamphetamine and calcium carbonate, underscoring the need for clinician‑driven timing and monitoring strategies. American Academy of Child and Adolescent Psychiatry guidance. 2